EFSA Journal,
Journal Year:
2024,
Volume and Issue:
22(11)
Published: Nov. 1, 2024
Abstract
Vitamins
and
essential
minerals
are
micronutrients
that
required
for
the
normal
functioning
of
human
body.
However,
they
may
lead
to
adverse
health
effects
if
consumed
in
excess.
A
tolerable
upper
intake
level
(UL)
is
a
science‐based
reference
value
supports
policy‐makers
other
relevant
actors
managing
risks
excess
nutrient
intake.
EFSA's
principles
establishing
ULs
vitamins
were
originally
developed
by
Scientific
Committee
on
Food
2000.
This
guidance
from
EFSA
Panel
Nutrition,
Novel
Foods
Allergens
provides
an
updated
framework
UL
assessments.
draft
was
published
2022
underwent
2‐year
piloting
period.
The
present
document
incorporates
revisions
based
experience
gained
through
its
practical
implementation.
It
covers
aspects
related
planning
risk
assessment
(problem
formulation
definition
methods)
implementation
(evidence
retrieval,
appraisal,
synthesis,
integration,
uncertainty
analysis).
As
previous
framework,
general
chemicals
food
applied,
i.e.
hazard
identification,
characterisation,
assessment,
characterisation.
Specific
nutrients
their
biochemical
physiological
roles
specific
selective
mechanisms
maintain
systemic
homeostasis
accumulation
Such
considerations
must
also
be
taken
into
account
when
conducting
assessments
nutrients.
EFSA Journal,
Journal Year:
2023,
Volume and Issue:
21(8)
Published: Aug. 1, 2023
Following
two
requests
from
the
European
Commission
(EC),
EFSA
Panel
on
Nutrition,
Novel
Foods
and
Food
Allergens
(NDA)
was
asked
to
deliver
a
scientific
opinion
revision
of
tolerable
upper
intake
level
(UL)
for
vitamin
D
propose
conversion
factor
(CF)
calcidiol
monohydrate
into
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(4), P. 768 - 768
Published: March 30, 2024
Vitamin
D
is
rightly
recognized
as
an
essential
key
factor
in
the
regulation
of
calcium
and
phosphate
homeostasis,
affecting
primary
adequate
bone
mineralization.
In
last
decades,
a
more
complex
wider
role
vitamin
has
been
postulated
demonstrated.
Cardiovascular
diseases
have
found
to
be
strongly
related
levels,
especially
its
deficiency.
Pre-clinical
studies
suggested
direct
several
pathophysiological
pathways,
such
endothelial
dysfunction
platelet
aggregation;
moreover,
observational
data
confirmed
relationship
with
different
conditions,
including
coronary
artery
disease,
heart
failure,
hypertension.
Despite
significant
evidence
available
so
far,
most
clinical
trials
failed
prove
any
positive
impact
supplements
on
cardiovascular
outcomes.
This
discrepancy
indicates
need
for
further
information
knowledge
about
metabolism
effect
system,
order
identify
those
patients
who
would
benefit
from
supplementation.
EFSA Journal,
Journal Year:
2024,
Volume and Issue:
22(7)
Published: July 1, 2024
The
EFSA
Scientific
Committee
has
updated
its
2010
Guidance
on
risk-benefit
assessment
(RBA)
of
foods.
update
addresses
methodological
developments
and
regulatory
needs.
While
it
retains
the
stepwise
RBA
approach,
provides
additional
methods
for
complex
assessments,
such
as
multiple
chemical
hazards
all
relevant
health
effects
impacting
different
population
subgroups.
guidance
includes
approaches
systematic
identification,
prioritisation
selection
hazardous
beneficial
food
components.
It
also
offers
updates
to
characterising
adverse
effects,
measures
effect
size
dose-response
modelling.
expands
options
risks
benefits,
incorporating
variability,
uncertainty,
severity
categorisation
ranking
(beneficial
or
adverse)
effects.
impact
types
is
assessed
qualitatively
quantitatively,
depending
problem
formulation,
scope
question
data
availability.
integration
benefits
often
involves
value-based
judgements
should
ideally
be
performed
with
manager.
Metrics
Disability-Adjusted
Life
Years
(DALYs)
Quality-Adjusted
(QALYs)
can
used.
Additional
are
presented,
probability
and/or
given
severities
their
using
weight
functions.
practical
reporting
results,
interpreting
outcomes
communicating
outcome
an
RBA,
considering
consumer
perspectives
responses
advice.
Background
and
aims:
There
is
limited
data
regarding
the
vitamin
D
status
of
infants
young
children
in
Norway.
We
aimed
to
assess
among
Norwegian
at
approximately
6
12
months
age
explore
associations
between
child
status,
dietary
factors,
maternal
status.
Methods:
Mothers/parents
completed
a
food
frequency
questionnaire
for
their
6/12-month-old
child.
Dried
blood
spot
samples
were
collected
from
mother
Results:
The
mean
serum
25-hydroxyvitamin
(S-25(OH)D)
concentration
was
81
nmol/L
(standard
deviation
[SD]
22
nmol/L)
6-month-old
(n
=
84)
72
(SD
12-month-old
56)
(P
0.03
difference
groups).
In
younger
older
groups,
94
88%
children,
respectively,
had
S-25(OH)D
≥
50
nmol/L.
intake
μg/day
6-month-olds
14
12-month-olds.
Adjusted
linear
regression
models
showed
that
every
increase
intake,
25(OH)D
(nmol/L)
increased
by
around
one
both
groups
0.002
group
P
0.04
group).
Use
supplements
associated
with
higher
concentrations
while
formula
users
found
only
youngest
group.
Breastfeeding
not
either
Small
positive
correlations
observed
(r
0.22)
0.28)
Conclusion:
While
there
wide
range
most
within
sufficient
range.
Adequate
should
be
encouraged
first
second
year
life.
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 7, 2025
Vitamin
E,
primarily
in
its
active
form
α-tocopherol,
is
a
well-known
antioxidant
that
protects
cells
from
oxidative
stress
and
free
radical
damage.
It
plays
an
essential
role
maintaining
cellular
integrity
supporting
immune
function,
making
E
widely
popular
easily
accessible
dietary
supplement
for
overall
health
wellness.
However,
high-dose
supplementation
has
become
concern
related
to
potential
risks.
The
scientific
research
surrounding
the
safety
efficacy
of
complex
yet
emphasizes
balance
use
supplementation.
Excessive
or
causes
shift
this
balance,
as
E's
beneficial
properties
are
outweighed
by
harmful
interference
normal
processes
such
immunity,
cell
growth,
stress.
An
additional
complication
involves
anticoagulant
effects,
which
have
been
shown
amplify
risk
bleeding
when
combined
with
blood
thinners
warfarin
aspirin.
Studies
linked
adverse
outcomes,
including
enhanced
risks
all-cause
mortality,
hemorrhagic
stroke,
cardiovascular
events,
certain
cancers.
These
particularly
significant
individuals
pre-existing
conditions
heart
failure,
coagulation
disorders,
history
stroke.
side
effects
need
further
into
This
review
will
provide
comprehensive
analysis
multifaceted
physiology,
focusing
on
navigating
between
benefits
European Journal of Clinical Nutrition,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 19, 2025
Abstract
Background/Objective
Vitamin
D
deficiency
(serum
25-hydroxyvitamin
[25(OH)D]
concentration
<
50
nmol/L)
is
prevalent
among
Aboriginal
and
Torres
Strait
Islander
peoples
in
Australia.
Alternative
to
sun
exposure
(the
primary
source
of
vitamin
D),
can
also
be
obtained
from
food
(e.g.
fish,
eggs,
meat)
supplements.
However,
the
intake
this
population
group
unknown.
We
aimed
provide
first
quantification
using
nationally
representative
data
peoples.
Methods
used
consumption
collected
2012–2013
National
Nutrition
Physical
Activity
Survey
(
n
=
4109)
composition
quantify
by
sex,
age
group,
remoteness
location.
Wilcoxon
rank-sum
test
was
assess
difference
between
sexes
Results
The
median
(25th,
75th
percentile)
aged
≥
2
years
80
(45,
145)
IU/day.
statistically
significantly
different
males
females
p
0.001).
There
no
significant
non-remote
remote
areas
0.292).
Conclusions
low.
Food-based
public
health
strategies
guided
Elders
communities
could
developed
promote
higher
population.
Journal of Pediatric Gastroenterology and Nutrition,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 24, 2025
Abstract
Objectives
Allogeneic
hematopoietic
stem
cell
transplantation
(HSCT)
is
associated
with
nutritional
risks.
This
study
describes
vitamin
D
status
and
intake
in
children
undergoing
HSCT
compares
results
to
healthy
children.
Methods
In
a
prospective
observational
study,
25(OH)D
1,25(OH)
2
were
assessed
at
hospital
admission
before
(baseline),
3‐month
1‐year
post‐transplant.
Vitamin
deficiency
was
defined
as
<
50
nmol/L.
A
4‐day
diet
record
3‐months
1‐year.
Healthy
once.
Results
Twenty‐eight
patients
(mean
age:
10.3‐years,
standard
deviation
[SD]:
4.0)
10.0‐years,
SD:
3.6)
included.
more
prevalent
baseline
(36%,
p
0.001)
(24%,
=
0.007)
but
not
(14%,
0.084)
than
(2%).
Median
significantly
lower
the
two
first
visits
(
0.198).
provision
higher
(18.1
µg/day)
(25
compared
(5.3
µg/day,
0.001).
Conclusions
Children
high
risk
of
post‐transplant,
after
These
findings
indicate
that
requirements
are
elevated
patients,
emphasizing
need
for
monitoring
adequate
supplementation.
Trial
Registration
Clinical
Trials
AEV2017/1.
2016/391/REK
sør‐øst
B.